LDS/Medical Tests/Cytochrome P450 6A2 (CYP6A2) Genotyping

Cytochrome P450 6A2 (CYP6A2) Genotyping

Cytochrome P450 6A2 (CYP6A2) belongs to the superfamily of cytochrome P450 enzymes. The gene codes for cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG).

In humans, the gene is observed to be associated with B-lymphoblastic leukemia/lymphoma, acute lymphoid leukemia, and chronic myeloid leukemia. It has also been shown associated with familial Mediterranean fever.

Also, CYP6A2 has been shown to be involved in cancer drug metabolism especially those used for lymphoma and leukemia.

  • Possible aid in the diagnosis of B-lymphoblastic, acute lymphoid, and chronic myeloid leukemia
  • As an aid in the diagnosis of familial Mediterranean fever
  • Useful in therapy (chemotherapy) selection and management
A positive result indicates the presence of variants in the CYP6A2 gene. A negative result indicates the absence of variants in the CYP6A2 gene.

Normal variant

Allele Specific Primer Extension (ARMS) by Real-time Polymerase chain reaction (PCR), Next generation sequencing (NGS), Conventional Sequencing.

Whole blood, Lavender-top (EDTA) top tube, buccal swab.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7 days
  • Frozen: unstable
CBC with differential, peripheral blood smear examination, bone marrow examination, immunophenotyping, cytogenetics by FISH, BCR/ABL gene locus analysis, MEFV gene mutation analysis.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • DNA Cell Biol. 1997: 11;16(11):1345-56 [PMID: 9407006]
  • Philos Trans R Soc Lond B Biol Sci. 2013: 1;368(1612):20120431 [PMID: 23297354]
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login